4//SEC Filing
BONNEY MICHAEL W 4
Accession 0001735276-25-000087
CIK 0001178670other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:26 PM ET
Size
9.3 KB
Accession
0001735276-25-000087
Insider Transaction Report
Form 4
BONNEY MICHAEL W
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-08-18−11,250→ 0 totalExercise: $70.20From: 2017-06-03Exp: 2026-06-03→ Common Stock (11,250 underlying) - Sale
Common Stock
2025-08-18$450.00/sh−11,250$5,062,500→ 16,804 total - Exercise/Conversion
Common Stock
2025-08-18$70.20/sh+11,250$789,750→ 28,054 total
Holdings
- 4,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024.
- [F2]The shares of ALNY common stock were purchased by the Michael W. Bonney Revocable Trust, of which the reporting person is trustee.
- [F3]The stock option was fully vested as of June 3, 2017.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeother
Related Parties
1- filerCIK 0001219016
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 5:26 PM ET
- Size
- 9.3 KB